Performance of ARWR Arrowhead Pharmaceutica.. | -28.1% in 12m

Compare ARWR with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare Arrowhead Pharmaceutica.. with its related Sector/Index XBI

Compare Arrowhead Pharmaceutica.. with its related Sector/Index XBI

Performance Duell ARWR vs XBI

TimeFrame ARWR XBI
1 Day -4.82% -1.12%
1 Week -11.3% -5.89%
1 Month -19.9% -8.93%
3 Months -33.9% -4.18%
6 Months -16.6% 20.43%
12 Months -28.1% 3.47%
YTD -27.4% -6.18%
Rel. Perf. 1m -0.97
Rel. Perf. 3m -1.51
Rel. Perf. 6m -3.25
Rel. Perf. 12m -3.33

Is Arrowhead Pharmaceutica.. a good stock to buy?

No, based on ValueRay Fundamental Analyses, Arrowhead Pharmaceutica.. (NASDAQ:ARWR) is currently (April 2024) a stock to sell. It has a ValueRay Fundamental Rating of -8.50 and therefor a negative outlook according to fundamental data.
Based on ValueRays Technical Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARWR as of April 2024 is 19.56. This means that ARWR is currently overvalued and has a potential downside of -13.18%.

Is ARWR a buy, sell or hold?

  • Strong Buy: 7
  • Buy: 3
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
Arrowhead Pharmaceutica.. has received a consensus analysts rating of 4.21. Therefor, it is recommend to buy ARWR.
Values above 0%: ARWR is performing better - Values below 0%: ARWR is underperforming

Compare ARWR with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY -8.62% -17.54% -32.24% -50.78%
US NASDAQ 100 QQQ -8.40% -17.28% -32.72% -62.56%
US Dow Jones Industrial 30 DIA -9.42% -17.29% -28.68% -41.30%
German DAX 40 DBXD -9.41% -19.01% -32.99% -40.06%
UK FTSE 100 ISFU -9.40% -19.79% -22.87% -32.34%
Shanghai Shenzhen CSI 300 CSI 300 -13.40% -18.17% -15.25% -10.77%
Hongkong Hang Seng HSI -5.29% -10.65% -3.15% -0.72%
Japan Nikkei 225 EXX7 -7.43% -14.49% -30.13% -46.49%
India NIFTY 50 INDA -8.87% -20.47% -30.47% -55.71%
Brasil Bovespa EWZ -5.31% -14.25% -18.58% -37.70%

ARWR Arrowhead Pharmaceutica.. vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC -8.81% -19.02% -34.14% -65.15%
Consumer Discretionary XLY -7.75% -16.20% -23.47% -45.50%
Consumer Staples XLP -10.01% -17.18% -26.51% -27.93%
Energy XLE -7.52% -23.22% -21.75% -41.09%
Financial XLF -8.33% -17.05% -35.35% -49.57%
Health Care XLV -9.04% -15.53% -23.16% -32.76%
Industrial XLI -8.86% -19.31% -35.04% -50.49%
Materials XLB -8.41% -18.13% -30.23% -39.69%
Real Estate XLRE -6.31% -12.10% -21.97% -26.97%
Technology XLK -8.40% -16.33% -34.42% -62.48%
Utilities XLU -10.12% -21.28% -25.77% -23.80%
Aerospace & Defense XAR -9.08% -16.84% -29.47% -42.25%
Biotech XBI -5.37% -11.01% -37.05% -31.58%
Homebuilder XHB -7.81% -16.22% -50.78% -78.04%
Retail XRT -7.58% -13.63% -32.73% -42.80%

ARWR Arrowhead Pharmaceutica.. vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO -7.39% -21.13% -16.76% -39.50%
Natural Gas UNG -3.03% -13.68% 33.31% 21.47%
Gold GLD -13.11% -29.72% -39.78% -46.47%
Silver SLV -12.83% -32.77% -40.19% -40.40%
Copper CPER -12.94% -25.49% -39.10% -37.13%

Returns of ARWR vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT -10.22% -16.62% -23.41% -17.28%
iShares High Yield Corp. Bond HYG -10.34% -18.54% -24.56% -35.26%
Does Arrowhead Pharmaceutica.. outperform its market, is ARWR a Sector Leader?
No, over the last 12 months Arrowhead Pharmaceutica.. (ARWR) made -28.11%, while its related Sector, the SPDR S&P Biotech (XBI) made 3.47%.
Over the last 3 months ARWR made -33.85%, while XBI made -4.18%.
Period ARWR XBI S&P 500
1 Month -19.94% -8.93% -2.40%
3 Months -33.85% -4.18% 6.31%
12 Months -28.11% 3.47% 22.67%